Company · CIK 0001720893 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
BioXcel Therapeutics, Inc. · BTAI
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 MForm 4 → | Jun 17, 8:01 pm EDT | Javier RodriguezSee Remarks | 35 | — | — | 26,838 | — | |
| Jun 15, 2026 MForm 4 → | Jun 17, 8:00 pm EDT | Richard I SteinhartChief Financial Officer | 35 | — | — | 26,335 | — | |
| Jun 15, 2026 MForm 4 → | Jun 17, 8:00 pm EDT | Frank YoccaChief Scientific Officer | 35 | — | — | 26,210 | — | |
| Jun 15, 2026 MForm 4 → | Jun 17, 8:00 pm EDT | Vimal MehtaCEO and President, Director | 219 | — | — | 69,817 | — | |
| Dec 14, 2018 PForm 4 → | Dec 14, 4:30 pm EST | Vimal MehtaCEO, President, Secretary, Director | 2,000 | $4.38 | $8,766 | 5,000 | +66.7% | plan? |
| Dec 6, 2018 PForm 4 → | Dec 7, 5:50 pm EST | Peter MuellerDirector | 8,795 | $5.01 | $44,045 | 158,320 | +5.88% | plan? |
| Dec 4, 2018 PForm 4 → | Dec 6, 5:34 pm EST | Peter MuellerDirector | 4,007 | $5.13 | $20,544 | 149,525 | +2.75% | plan? |
| Dec 4, 2018 PForm 4 → | Dec 4, 5:05 pm EST | Vimal MehtaCEO, President, Secretary, Director | 1,000 | $5.12 | $5,120 | 3,000 | +50.0% | plan? |
| Dec 3, 2018 PForm 4 → | Dec 6, 6:04 am EST | Frank YoccaChief Scientific Officer | 900 | $5.21 | $4,692 | 1,850 | +94.7% | plan? |
| Dec 3, 2018 PForm 4 → | Dec 4, 10:22 am EST | Vimal MehtaCEO, President, Secretary, Director | 1,000 | $5.17 | $5,165 | 2,000 | +100% | plan? |
| Dec 3, 2018 PForm 4 → | Dec 4, 9:49 am EST | Richard I SteinhartChief Financial Officer | 500 | $5.20 | $2,600 | 1,500 | +50.0% | plan? |
| Nov 30, 2018 PForm 4 → | Nov 30, 5:36 pm EST | Richard I SteinhartChief Financial Officer | 500 | $5.00 | $2,500 | 1,000 | +100% | plan? |
| Nov 30, 2018 PForm 4 → | Nov 30, 5:35 pm EST | Frank YoccaChief Scientific Officer | 450 | $5.20 | $2,340 | 950 | +90.0% | plan? |
| Nov 30, 2018 PForm 4 → | Nov 30, 4:10 pm EST | Vimal MehtaCEO, President, Secretary, Director | 1,000 | $5.10 | $5,104 | 1,000 | — | plan? |
| Nov 29, 2018 PForm 4 → | Nov 30, 4:17 pm EST | Krishnan NandabalanDirector, 10% Owner | 1,000 | $4.92 | $4,915 | 1,000 | — | plan? |
| Nov 29, 2018 PForm 4 → | Nov 30, 2:31 pm EST | Frank YoccaChief Scientific Officer | 500 | $5.02 | $2,511 | 500 | — | plan? |
| Nov 29, 2018 PForm 4 → | Nov 30, 2:30 pm EST | Richard I SteinhartChief Financial Officer | 500 | $5.00 | $2,500 | 500 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 AForm 4 → | Aug 14, 7:00 pm EDT | Susan E. AtkinsDirector | 17,000 | — | — | 17,000 | — | |
| Jun 15, 2026 MForm 4 → | Jun 17, 8:01 pm EDT | Javier RodriguezSee Remarks | 35 | — | — | 212 | — | |
| Jun 15, 2026 MForm 4 → | Jun 17, 8:00 pm EDT | Richard I SteinhartChief Financial Officer | 35 | — | — | 212 | — | |
| Jun 15, 2026 MForm 4 → | Jun 17, 8:00 pm EDT | Frank YoccaChief Scientific Officer | 35 | — | — | 212 | — | |
| Jun 15, 2026 MForm 4 → | Jun 17, 8:00 pm EDT | Vimal MehtaCEO and President, Director | 219 | — | — | 1,313 | — | |
| Mar 12, 2018 AForm 4 → | Mar 13, 5:13 pm EDT | Sandeep LaumasDirector | 37,209 | — | — | 124,188 | — | |
| Mar 12, 2018 AForm 4 → | Mar 13, 5:12 pm EDT | Richard I SteinhartChief Financial Officer | 32,232 | — | — | 116,130 | — | |
| Mar 12, 2018 AForm 4 → | Mar 13, 5:12 pm EDT | Peter MuellerDirector | 37,209 | — | — | 161,397 | — | |
| Mar 12, 2018 AForm 4 → | Mar 13, 5:11 pm EDT | Frank YoccaChief Scientific Officer | 36,498 | — | — | 185,808 | — | |
| Mar 12, 2018 AForm 4 → | Mar 13, 5:10 pm EDT | Vincent O'NeillChief Medical Officer | 31,047 | — | — | 155,472 | — |